Log in

Agios Pharmaceuticals SEC Filings & 10K Form (NASDAQ:AGIO)

$32.35
-0.27 (-0.83 %)
(As of 10/15/2019 06:00 AM ET)
Today's Range
$31.48
Now: $32.35
$33.08
50-Day Range
$31.23
MA: $35.44
$39.75
52-Week Range
$31.02
Now: $32.35
$74.25
Volume405,176 shs
Average Volume577,975 shs
Market Capitalization$1.90 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.31

SEC Filings

Agios Pharmaceuticals (NASDAQ:AGIO) SEC Filings

DateFilerForm TypeView
10/09/2019
3:20 PM
Agios Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
09/30/2019
10:13 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
4:05 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
7:56 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
6:29 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
11:41 AM
Agios Pharmaceuticals (Filer)
Form CT ORDER
06/13/2019
3:07 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:08 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
3:02 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:08 PM
Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:08 PM
Agios Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:07 PM
Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:05 PM
Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:05 PM
Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:04 PM
Agios Pharmaceuticals (Issuer)
CLARK IAN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:03 PM
Agios Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:13 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
2:24 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
7:57 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
6:24 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
10:46 AM
Agios Pharmaceuticals (Filer)
Form CT ORDER
04/26/2019
10:06 AM
Agios Pharmaceuticals (Filer)
Form CT ORDER
04/24/2019
4:38 PM
Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
3:07 PM
Agios Pharmaceuticals (Filer)
Form DEFA14A
04/18/2019
3:04 PM
Agios Pharmaceuticals (Filer)
Form DEF 14A
04/09/2019
3:59 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
3:25 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:06 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:04 PM
Agios Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:27 PM
Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:25 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:24 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:21 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:02 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2019
3:03 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:05 PM
Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:04 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:03 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:01 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
8:07 AM
Agios Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2019
7:48 AM
Agios Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
6:16 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
10:18 AM
Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/05/2019
3:28 PM
Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
9:09 AM
Agios Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/31/2019
2:03 PM
Agios Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
Form SC 13G/A
01/28/2019
3:01 PM
Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
Form SC 13G/A
01/23/2019
3:22 PM
Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:19 PM
Agios Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:12 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:48 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2018
3:39 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2018
3:30 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2018
3:03 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2018
3:01 PM
Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
3:01 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:09 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
3:12 PM
Agios Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4/A
11/01/2018
8:33 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
6:45 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
3:09 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2018
3:01 PM
Agios Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2018
3:12 PM
Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2018
3:22 PM
Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2018
3:18 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2018
3:12 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
5:43 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
5:05 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2018
3:02 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2018
3:06 PM
Agios Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2018
8:05 AM
Agios Pharmaceuticals (Filer)
Form CT ORDER
08/21/2018
2:30 PM
Agios Pharmaceuticals (Filer)
Form CT ORDER
08/10/2018
4:20 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4/A
08/10/2018
4:19 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4/A
08/10/2018
4:19 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4/A
08/10/2018
4:18 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4/A
08/10/2018
4:17 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4/A
08/10/2018
4:16 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4/A
08/08/2018
3:14 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
8:02 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2018
6:28 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2018
3:01 PM
Agios Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2018
3:37 PM
Agios Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2018
3:34 PM
Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2018
3:32 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2018
10:21 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2018
3:14 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
3:23 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2018
3:08 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2018
3:06 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2018
3:02 PM
Agios Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:05 PM
Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:23 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2018
3:02 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
3:28 PM
Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
3:19 PM
Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
3:17 PM
Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
3:10 PM
Agios Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
8:16 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2018
3:08 PM
Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Featured Article: Dividend Aristocrat Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel